{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-021134","form_type":"8-K","ticker":"GNPX","cik":"0001595248","company_name":"Genprex, Inc.","filed_at":"2026-06-18T20:01:04+00:00","discovered_at":"2026-06-18T20:02:00.344717+00:00","generated_at":"2026-06-18T20:08:09.122662+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Genprex stockholders approve reverse stock split authorization and 1.85M share increase to equity plan","bullets":["Stockholders approved amendment to certificate of incorporation to effect reverse stock split at ratio from 1:5 to 1:50, at board's discretion before Dec 31, 2027.","Amended and restated 2018 Equity Incentive Plan approved, increasing authorized shares by 1,850,000.","Class III directors Jose Antonio Moreno Toscano and Ryan M. Confer elected with 868,543 and 877,370 votes for, respectively.","Ratification of WithumSmith+Brown as independent auditor for FY2026 approved with 4,284,497 votes for.","Advisory vote on NEO compensation passed with 681,841 votes for, 328,425 against."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-021134","json":"https://secwatch.observer/filing/0001437749-26-021134.json","markdown":"https://secwatch.observer/filing/0001437749-26-021134.md","text":"https://secwatch.observer/filing/0001437749-26-021134.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595248/000143774926021134/0001437749-26-021134-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595248/000143774926021134/gnpx20260615_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T20:08:09.122662+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"120d1bc5e6c8210fde294867bd4aa45ea04db9c8","claim":"Genprex, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-18 meeting.","evidence_excerpt":"Proposal 2. Ratification of Appointment of Independent Registered Public Accounting Firm. The proposal to ratify the appointment of WithumSmith+Brown, PC as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026 was approved by the stockholders based upon the following votes: Votes For Votes Against Abstention Broker Non-Votes 4,284,497 254,937 55,594 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774926021134/0001437749-26-021134-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-18"}],"fact_type":"shareholder_vote"},{"claim_id":"2649c5d95c131714abb132b23a3b2889348ff132","claim":"Genprex, Inc. shareholders approved Election of Directors at the 2026-06-18 meeting.","evidence_excerpt":"Proposal 1. Election of Directors. The Class III director nominees, Jose Antonio Moreno Toscano and Ryan M. Confer, were elected to serve until the 2029 annual meeting of stockholders and until their respective successors have been duly elected and qualified, or until each such director’s earlier resignation, removal or death. The result of the votes to elect the Class III directors were as follows: Name Votes For Votes Withheld Broker Non-Votes Jose Antonio Moreno Toscano 868,543 176,863 3,549,622 Ryan M. Confer 877,370 168,036 3,549,622","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774926021134/0001437749-26-021134-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-18"}],"fact_type":"shareholder_vote"},{"claim_id":"6d8d81d9b46d71b06f2f8d4ed07bc030f9afecc8","claim":"Genprex, Inc. shareholders approved Approval of the Amended and Restated 2018 Equity Incentive Plan at the 2026-06-18 meeting.","evidence_excerpt":"Proposal 4. Approval of the Company’ s Amended and Restated 2018 Equity Incentive Plan. The proposal to approve the Amended Equity Plan was approved by the stockholders based upon the following votes: Votes For Votes Against Abstention Broker Non-Votes 675,090 337,920 32,396 3,549,622","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774926021134/0001437749-26-021134-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-18"}],"fact_type":"shareholder_vote"},{"claim_id":"d020373476157566b157bce63f5b51df8f9f69c2","claim":"Genprex, Inc. shareholders approved Advisory Vote on Compensation of Named Executive Officers at the 2026-06-18 meeting.","evidence_excerpt":"Proposal 3. Advisory Vote on Compensation of Named Executive Officers ( “ NEOs ” ). The votes were cast as follows with respect to the proposal to vote, on an advisory basis, on the compensation of the Company’s NEOs as described in the Company’s Proxy Statement: Votes For Votes Against Abstention Broker Non-Votes 681,841 328,425 35,140 3,549,622","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774926021134/0001437749-26-021134-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-18"}],"fact_type":"shareholder_vote"},{"claim_id":"eff080875f141ea70dee7e47e1e24a79a676f8fc","claim":"Genprex, Inc. shareholders approved Adoption and Approval of Amendment to the Certificate of Incorporation to effect a reverse stock split at the 2026-06-18 meeting.","evidence_excerpt":"Proposal 5. Adoption and Approval of Amendment to the Company’s Amended and Restated Certificate of Incorporation. The amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company’s issued shares of common stock, at a specific ratio, ranging from one-for-five (1:5) to one-for-fifty (1:50), at any time prior to December 31, 2027, subject to the Company’s Board of Directors’ determination, in its sole discretion, whether or not to implement the reverse stock split and, if so, at what specific ratio within the foregoing range, without further approval or authorization of the Company’s stockholders, was approved by the stockholders upon the following votes: Votes For Votes Against Abstention Broker Non-Votes 2,941,032 1,592,728 61,268 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774926021134/0001437749-26-021134-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-18"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}